IRESS Ltd
IRE: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| g | LOCK|lQy$ | LOCK|G&%l@%G |
Iress Earnings: Cost Cuts Buy Time, but Revenue Story Remains Challenged
Iress reported 34% growth in underlying net profit after tax in calendar 2025. Revenue and EBITDA grew 7% and 15%, respectively, with EBITDA margins expanding 2% to 26%. Management guided to EBITDA and NPAT growth of at least 15% in calendar 2026, with modest revenue growth. Shares rose 10%.
